Precipio, Inc. (NASDAQ:PRPO – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.88 and traded as high as $6.79. Precipio shares last traded at $6.79, with a volume of 319 shares.
Precipio Stock Up 0.7 %
The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.59 and a current ratio of 0.73. The company’s fifty day moving average is $6.11 and its 200-day moving average is $5.88.
Precipio (NASDAQ:PRPO – Get Free Report) last posted its quarterly earnings data on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter. The firm had revenue of $4.44 million for the quarter. Precipio had a negative return on equity of 39.66% and a negative net margin of 22.90%.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Read More
- Five stocks we like better than Precipio
- 3 Grocery Stocks That Are Proving They Are Still Essential
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Dividend Payout Ratio Calculator
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Most Volatile Stocks, What Investors Need to Know
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
